Ann: PharmAust's Phase 1 Study Data Presented at Major Conference, page-9

Yes statistically you are correct ,,, in essence PAA MND Trial Patients have outlived the Disease Prognosis identified for term of survival.

The slope change would crystalise as a real world term, from being absolutely f@^#ing exceptional to just absolutely exceptional..

There was a previous post back in the threads that denoted the actual term of life from Diagnosis , remember to take into account some of the PAA Trial Patients had been diagnosed months and years earlier... they were not recently diagnosed and then immediately began the trial..

There will obviously be some future Trial Participants that go immediately onto MPL within weeks of Diagnosis ,,, IMHO that will show an even greater significance as the Disease would not have been so progressed and therefor maybe able to be kept at bay for an even longer period...

That's what a wider Phase II will hopefully prove.... NZT